Boston Scientific (NYSE:BSX – Get Free Report) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Wednesday. Several other research analysts also ...

PFG Investments LLC boosted its stake in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 1.6% during the 4th quarter, according to the company in its most recent filing with the Securities ...

Corporation's stock has reached a new 52-week high, with shares climbing to $282.87. This milestone reflects a significant uptrend for the medical device company, known for its innovative insulin pump ...

Truist Securities, TD Cowen, Citigroup Inc. ( C) and Canaccord Genuity all also rate BSX "buy," while JPMorgan Chase & Co. ( ...

In a report released yesterday, Daniel Perlin from RBC Capital maintained a Buy rating on Mastercard (MA – Research Report), with a price ...

RBC Capital analyst Craig Wong-Pan maintained a Hold rating on Nanosonics Limited (NNCSF – Research Report) on January 29 and set a price ...

RBC Emerging Markets Equity Fund earns a High Process Pillar rating. The most important driver of the rating is its parent firm's excellent long-term risk-adjusted performance, as shown by the ...

LONDON - RBC Europe Limited, acting as the Stabilising Coordinator, has announced the possibility of market stabilization activities related to the offering of securities by the Royal Bank of ...

Dave McKay, president and chief executive officer of Royal Bank of Canada (RY on TSX and NYSE), is scheduled to speak at the RBC Capital Markets Canadian Bank CEO Conference on January 7 ...

Buying $1000 In BSX: If an investor had bought $1000 of BSX stock 5 years ago, it would be worth $2,432.39 today based on a ...